Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Today is World Hepatitis Day. OUCRU and hospitals in Ho Chi Minh City and Hanoi have been collaborating on hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy. OUCRU’s social science and public engagement teams are currently working with underrepresented groups to create community-led strategies to link care and treatment for populations at risk for viral hepatitis. Our aim is to have a more significant impact on the treatment strategy and access to care for patients with hepatitis C in Vietnam and worldwide in the future.

Stakeholders mapping meeting with members of community-based organizations representing and supporting underserved communities at risk of Hep C in HCMC
Stakeholders meeting with members of community-based organizations representing and supporting underserved communities at risk of Hep C in Ho Chi Minh City

To date, these clinical trials have recruited from populations already engaged in care at the Hospital for Tropical Diseases. Participants are aware of hepatitis C virus infection and its implications and are well-motivated to seek treatment. Since our clinical trials are investigating the efficacy of treatment strategies that could be used to treat underserved populations, it is crucial to develop innovative ways to engage with these ‘hard-to-reach’ populations, such as people who inject drugs, men who have sex with men, commercial sex workers, as well as low-income communities.

OUCRU’s social science and public engagement teams are currently working with these underrepresented groups, using community-based participatory research to engage with communities to create community-led strategies to improve linkages to care and treatment for populations at risk for viral hepatitis.

These studies are currently ongoing, with a positive impact on the participants. We hope to have a more significant impact on the treatment strategy and access to care for patients with hepatitis C in Vietnam and worldwide in the future.

The full story is available on the OUCRU website

Read the publications 'Seroprevalence of Hepatitis B, C and D in Vietnam: A systematic review and meta-analysis' on The Lancet website

Similar stories

Letter from the hills: The invisible burden of leprosy in Sumba

OUCRU Indonesia launches a new exhibition by photographer Yoppy Pieter based in Jakarta, Indonesia. This exhibition documents, through a series of intimate and beautiful images, the invisible burden of leprosy and other skin diseases in Sumba, an island in Nusa Tenggara Timor province, Indonesia.

Combating Antimicrobial Resistance

November 18 – 24 is World Antimicrobial Awareness Week. Antimicrobial resistance has been a key focus in OUCRU’s research for many years. Our objective is to understand and improve antimicrobial use and antimicrobial resistance in agriculture, the community, and hospitals. Our approach is interdisciplinary – led by a number of OUCRU’s research groups and public engagement teams.

OUCRU Engagement around mental health

OUCRU’s Public and Community Engagement team develops training and resources on the topic of stress management and communication skills. Run by the Public and Community Engagement team, the Youth Ambassadors programme also links young people to medical research that impacts their lives and connects researchers to the health issues that young people care about.

Abhilasha Karkey, new OUCRU Nepal Director

OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.

OUCRU presents a new virtual exhibition: Digital Diaries, Voices from the Pandemic, COVID-19 experiences in Asia

This online exhibition showcases short films and photographs created by health-care workers and community members and documents the socio-cultural impact of the COVID-19 pandemic in Indonesia, Nepal and Vietnam.

Prof Guy Thwaites co-authored WHO’s report on antibacterial agents in preclinical & clinical development

OUCRU’s Director, Professor Guy Thwaites, has recently contributed to an analysis of antibacterial agents in preclinical and clinical development by the World Health Organisation (WHO), as part of the WHO advisory group on research and development of antibacterial treatments.